(Q35194486)

7 August 2017

1 reference

title

A safety look at currently available statins (English)

1 reference

7 August 2017

author name string

Mohammed H Moghadasian

series ordinal

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Expert Opinion on Drug Safety

7 August 2017

published in

1 reference

7 August 2017

volume

1

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

269-274

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Depressive symptoms in hypercholesterolaemic patients treated with pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Statins and peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Circulation impact factor is highest ever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Cerivastatin and reports of fatal rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

Withdrawal of statins increases event rates in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.1.3.269

21 January 2018

Identifiers

DOI

10.1517/14740338.1.3.269

1 reference

7 August 2017

1 reference